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Background:  Ascending aortic pseudo-aneurysms (PSA) is a rare and potentially fatal complication of cardiovascular surgery. 
Endovascular intervention of aortic PSA has been rarely described as a minimally invasive alternative to conventional open repair.
case:  An 82-year-old patient underwent aortic valve replacement for severe aortic stenosis and coronary artery bypass grafting with a left 
internal mammary artery to the left anterior descending artery. He had a prolonged post-operative recovery complicated by sternal wound 
infection, and subsequent plastics flap closure. Incidentally, the patient was found to have a complex 1.7 cm mycotic PSA of the ascending 
aorta, 5 cm above the take off of the coronary ostia.
decision Making:  Surgical repair of ascending aortic PSA is associated with significant morbidity and mortality (>17%). Given the patient 
was blood culture negative and afebrile, an endovascular repair would be advantageous over an open repair and standard thoracic 
endografts were not deemed suitable. Due to the lack of conventional access, the decision was made to intervene on the PSA from a right 
axillary/subclavian endovascular approach. An Excluder Abdominal Aortic Extenders (EAAE) (Gore®) was introduced via a right axillary 
artery cut down with complete resolution of the PSA. A second EAAE was deployed to assist in structural support in the setting of the high 
velocity and pulsatility present in the proximal aorta. At six month follow up the patient remains asymptomatic, free of infection and CT scan 
with contrast revealed no evidence of a recurrent PSA.
conclusion:  In the setting of a re-operative high risk patient with an aortic PSA, endovascular therapy is a safe and effective alternative to 
conventional surgery. The success in deploying the EAAE via an axillary cut down adds to the existing armamentarium, while providing a 
potentially superior approach.
